Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KRYS
DateHeureSourceTitreSymboleSociété
08/06/202400h09PR Newswire (US)KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:KRYSKrystal Biotech Inc
05/06/202413h00GlobeNewswire Inc.Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
21/05/202422h38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
15/05/202413h00GlobeNewswire Inc.Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceNASDAQ:KRYSKrystal Biotech Inc
08/05/202413h00GlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
06/05/202414h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
06/05/202414h09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:KRYSKrystal Biotech Inc
06/05/202414h00GlobeNewswire Inc.Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
02/05/202413h00GlobeNewswire Inc.Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
26/04/202413h00GlobeNewswire Inc.Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024NASDAQ:KRYSKrystal Biotech Inc
22/04/202413h00GlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
04/04/202413h00GlobeNewswire Inc.Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
02/03/202402h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
28/02/202413h00GlobeNewswire Inc.Krystal Biotech to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
26/02/202419h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
26/02/202414h00GlobeNewswire Inc.Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
26/02/202413h59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRYSKrystal Biotech Inc
26/02/202413h49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRYSKrystal Biotech Inc
26/02/202411h57IH Market NewsU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices RetreatNASDAQ:KRYSKrystal Biotech Inc
20/02/202413h00GlobeNewswire Inc.Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:KRYSKrystal Biotech Inc
13/02/202413h00GlobeNewswire Inc.Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
08/02/202413h00GlobeNewswire Inc.Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
01/02/202413h00GlobeNewswire Inc.Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:KRYSKrystal Biotech Inc
04/01/202413h00GlobeNewswire Inc.Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®NASDAQ:KRYSKrystal Biotech Inc
19/12/202313h00GlobeNewswire Inc.Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)NASDAQ:KRYSKrystal Biotech Inc
27/11/202313h00GlobeNewswire Inc.Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
09/11/202313h00GlobeNewswire Inc.Krystal Biotech to Present at the Stifel 2023 Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
06/11/202313h00GlobeNewswire Inc.Krystal Biotech Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:KRYSKrystal Biotech Inc
30/10/202312h00GlobeNewswire Inc.Krystal Biotech to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:KRYSKrystal Biotech Inc
28/09/202313h00GlobeNewswire Inc.Krystal Biotech to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:KRYSKrystal Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:KRYS